3.0.0 1264 2026-01-09T23:44:00Z 2026-01-09T23:44:00Z Senate S S 2023-04-25 118 https://www.congress.gov/bill/118th-congress/senate-bill/1264 ssfi00 Finance Committee Senate Standing Referred To 2023-04-25T20:50:29Z 118 1246 S 2023-04-20 Read twice and referred to the Committee on Finance. Identical bill CRS 2023-04-25 ssfi00 Finance Committee Senate Read twice and referred to the Committee on Finance. IntroReferral 2023-04-25 Introduced in Senate IntroReferral 10000 9 Library of Congress K000367 Sen. Klobuchar, Amy [D-MN] Amy Klobuchar D MN N W000800 Sen. Welch, Peter [D-VT] Peter Welch D VT 2023-04-25 True G000555 Sen. Gillibrand, Kirsten E. [D-NY] Kirsten Gillibrand D NY E. 2023-04-25 True H001046 Sen. Heinrich, Martin [D-NM] Martin Heinrich D NM T. 2023-04-25 True M001176 Sen. Merkley, Jeff [D-OR] Jeff Merkley D OR 2023-04-25 True S000770 Sen. Stabenow, Debbie [D-MI] Debbie Stabenow D MI 2023-04-25 True R000122 Sen. Reed, Jack [D-RI] John Reed D RI F. 2023-04-25 True W000802 Sen. Whitehouse, Sheldon [D-RI] Sheldon Whitehouse D RI 2023-04-25 True B001277 Sen. Blumenthal, Richard [D-CT] Richard Blumenthal D CT 2023-04-25 True C001113 Sen. Cortez Masto, Catherine [D-NV] Catherine Cortez Masto D NV 2023-04-25 True H001076 Sen. Hassan, Margaret Wood [D-NH] Maggie Hassan D NH 2023-04-25 True K000383 Sen. King, Angus S., Jr. [I-ME] Angus King I ME S. 2023-04-25 True C000127 Sen. Cantwell, Maria [D-WA] Maria Cantwell D WA 2023-04-25 True S001181 Sen. Shaheen, Jeanne [D-NH] Jeanne Shaheen D NH 2023-04-25 True B001230 Sen. Baldwin, Tammy [D-WI] Tammy Baldwin D WI 2023-04-25 True D000563 Sen. Durbin, Richard J. [D-IL] Richard Durbin D IL J. 2023-04-25 True B000944 Sen. Brown, Sherrod [D-OH] Sherrod Brown D OH 2023-04-25 True B001288 Sen. Booker, Cory A. [D-NJ] Cory Booker D NJ 2023-04-25 True S001203 Sen. Smith, Tina [D-MN] Tina Smith D MN 2023-04-25 True W000817 Sen. Warren, Elizabeth [D-MA] Elizabeth Warren D MA A. 2023-04-25 True M001111 Sen. Murray, Patty [D-WA] Patty Murray D WA 2023-04-25 True C000141 Sen. Cardin, Benjamin L. [D-MD] Ben Cardin D MD 2023-04-25 True M000133 Sen. Markey, Edward J. [D-MA] Edward Markey D MA J. 2023-04-25 True D000622 Sen. Duckworth, Tammy [D-IL] Tammy Duckworth D IL 2023-04-25 True W000790 Sen. Warnock, Raphael G. [D-GA] Raphael Warnock D GA 2023-05-10 False V000128 Sen. Van Hollen, Chris [D-MD] Chris Van Hollen D MD 2023-05-11 False B001267 Sen. Bennet, Michael F. [D-CO] Michael Bennet D CO 2023-05-11 False F000479 Sen. Fetterman, John [D-PA] John Fetterman D PA K. 2023-05-11 False S000033 Sen. Sanders, Bernard [I-VT] Bernard Sanders I VT 2023-05-11 False M001169 Sen. Murphy, Christopher [D-CT] Christopher Murphy D CT S. 2023-07-26 False Health Health 2023-05-05T13:00:40Z

00 2023-04-25 Introduced in Senate 2023-11-29T22:07:36Z <p><b>Strengthening Medicare And Reducing Taxpayer Prices Act or the SMART Prices Act</b></p> <p>This bill modifies requirements of the Medicare Drug Price Negotiation Program and makes other changes with respect to the prices of prescription drugs under Medicare.</p> <p>Current law requires the Centers for Medicare &amp; Medicaid Services (CMS) to negotiate maximum prices for brand-name drugs that do not have other generic equivalents and that account for the greatest Medicare spending. The CMS must negotiate the prices of 10 drugs that are covered under the Medicare prescription drug benefit in 2026, 15 drugs that are covered under the Medicare prescription drug benefit in 2027, 15 drugs that are covered under the Medicare prescription drug benefit or under Medicare medical services in 2028, and 20 drugs that are covered under the Medicare prescription drug benefit or under Medicare medical services in 2029 and each year thereafter. </p> <p>The bill requires the CMS to negotiate the prices of 20 drugs under the Medicare prescription drug benefit in 2026 and 40 drugs under the Medicare prescription drug benefit or under Medicare medical services in 2027 and each year thereafter. It also (1) shortens the required period of market approval from 7 years and 11 years for drugs and biologics, respectively, to 3 years; and (2) modifies the ceiling for the maximum fair price for short-, extended-, and long-monopoly drugs.</p> <p>The bill also repeals provisions that prohibit the CMS from interfering in negotiations between drug manufacturers, pharmacies, and PDP sponsors (i.e., noninterference clause). </p>

Display Title 45 2024-07-24T15:22:33Z Short Title(s) as Introduced 101 2024-05-24T13:40:38Z Introduced in Senate IS Short Title(s) as Introduced 101 2024-05-24T13:40:38Z Introduced in Senate IS Official Title as Introduced 6 2023-05-03T03:13:49Z Introduced in Senate IS Introduced in Senate 2023-04-25T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-118s1264is/xml/BILLS-118s1264is.xml 2023-04-25 Read twice and referred to the Committee on Finance. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.